BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang B, Liu J, Xiong Y, Yan Y, Sun B, Zhao Q, Duan L, Li P, Huang Y, Chen W. Soluble E-cadherin as a serum biomarker in patients with HBV-related liver diseases. Clinical Biochemistry 2016;49:1232-7. [DOI: 10.1016/j.clinbiochem.2016.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang ZR, Chen H, Gao SS, Qiu H, Li HW, Sun ZL, Wang JM. Implications of soluble E-cadherin level of antiviral treatment in patients with chronic hepatitis C virus infection. Int Immunopharmacol 2019;74:105708. [PMID: 31254956 DOI: 10.1016/j.intimp.2019.105708] [Reference Citation Analysis]
2 Cheng L, Geng L, Dai B, Zheng T, Fu J, Qiao L, Cai W, Wang Y, Yang J. Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation. Cell Death Dis 2018;9:489. [PMID: 29695839 DOI: 10.1038/s41419-018-0477-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
3 Yang J, Xiong Y, Zhou L, Huang Y, Chen W, Wang B. Soluble E-cadherin is associated with oxidative stress in patients with chronic HBV infection. J Med Virol. 2020;92:34-44. [PMID: 31429942 DOI: 10.1002/jmv.25571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Tsaur I, Hüsch T, Jüngel E, Schneider F, Schneider M, Haferkamp A, Thomas C, Lieb V, Wach S, Taubert H, Chun FK, Blaheta RA. sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro. Urol Oncol 2019;37:355.e1-9. [PMID: 31005422 DOI: 10.1016/j.urolonc.2019.03.001] [Reference Citation Analysis]